<VariationArchive VariationID="2571196" VariationName="NM_006218.4(PIK3CA):c.1340_1366del (p.Pro447_Leu455del)" VariationType="Deletion" Accession="VCV002571196" Version="10" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-15" DateCreated="2023-07-17" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2736150" VariationID="2571196">
      <GeneList>
        <Gene Symbol="PIK3CA" FullName="phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha" GeneID="5290" HGNC_ID="HGNC:8975" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q26.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="179148126" stop="179240093" display_start="179148126" display_stop="179240093" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="178866310" stop="178952499" display_start="178866310" display_stop="178952499" Strand="+" />
          </Location>
          <OMIM>171834</OMIM>
          <Haploinsufficiency last_evaluated="2015-03-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PIK3CA">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-03-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PIK3CA">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006218.4(PIK3CA):c.1340_1366del (p.Pro447_Leu455del)</Name>
      <CanonicalSPDI>NC_000003.12:179210271:GCCAGTACCTCATGGATTAGAAGATTTGC:GC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q26.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="179210272" stop="179210298" display_start="179210272" display_stop="179210298" variantLength="27" positionVCF="179210271" referenceAlleleVCF="GGCCAGTACCTCATGGATTAGAAGATTT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="178928060" stop="178928086" display_start="178928060" display_stop="178928086" variantLength="27" positionVCF="178928059" referenceAlleleVCF="GGCCAGTACCTCATGGATTAGAAGATTT" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.178928062_178928088del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.178928062_178928088del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.179210274_179210300del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.179210274_179210300del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012113.2" sequenceAccession="NG_012113" sequenceVersion="2" change="g.66752_66778del">
            <Expression>NG_012113.2:g.66752_66778del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006218.4" sequenceAccession="NM_006218" sequenceVersion="4" change="c.1340_1366del" MANESelect="true">
            <Expression>NM_006218.4:c.1340_1366del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006209.2" sequenceAccession="NP_006209" sequenceVersion="2" change="p.Pro447_Leu455del">
            <Expression>NP_006209.2:p.Pro447_Leu455del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_310" sequenceAccession="LRG_310">
            <Expression>LRG_310:g.66752_66778del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_310t1" sequenceAccession="LRG_310t1">
            <Expression>LRG_310t1:c.1340_1366del27</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_310p1" sequenceAccession="LRG_310p1" change="p.Pro447_Leu455del">
            <Expression>LRG_310p1:p.Pro447_Leu455del</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006218.4(PIK3CA):c.1340_1366del (p.Pro447_Leu455del) AND not provided" Accession="RCV003312597" Version="9">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006218.4(PIK3CA):c.1340_1366del (p.Pro447_Leu455del) AND PIK3CA related overgrowth syndrome" Accession="RCV003458258" Version="1">
        <ClassifiedConditionList TraitSetID="23022">
          <ClassifiedCondition DB="MedGen" ID="C4728213">PIK3CA related overgrowth syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-06" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-06" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-07-17" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <DescriptionHistory Dated="2023-12-23">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="23022" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34372" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PIK3CA related overgrowth spectrum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PIK3CA-associated segmental overgrowth</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">PIK3CA related overgrowth syndrome</ElementValue>
                <XRef ID="737037004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PIK3CA-Related Segmental Overgrowth</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">PIK3CA-related overgrowth spectrum (PROS) encompasses a range of clinical findings in which the core features are congenital or early-childhood onset of segmental/focal overgrowth with or without cellular dysplasia. Prior to the identification of PIK3CA as the causative gene, PROS was separated into distinct clinical syndromes based on the tissues and/or organs involved (e.g., MCAP [megalencephaly-capillary malformation] syndrome and CLOVES [congenital lipomatous asymmetric overgrowth of the trunk, lymphatic, capillary, venous, and combined-type vascular malformations, epidermal nevi, skeletal and spinal anomalies] syndrome). The predominant areas of overgrowth include the brain, limbs (including fingers and toes), trunk (including abdomen and chest), and face, all usually in an asymmetric distribution. Generalized brain overgrowth may be accompanied by secondary overgrowth of specific brain structures resulting in ventriculomegaly, a markedly thick corpus callosum, and cerebellar tonsillar ectopia with crowding of the posterior fossa. Vascular malformations may include capillary, venous, and less frequently, arterial or mixed (capillary-lymphatic-venous or arteriovenous) malformations. Lymphatic malformations may be in various locations (internal and/or external) and can cause various clinical issues, including swelling, pain, and occasionally localized bleeding secondary to trauma. Lipomatous overgrowth may occur ipsilateral or contralateral to a vascular malformation, if present. The degree of intellectual disability appears to be mostly related to the presence and severity of seizures, cortical dysplasia (e.g., polymicrogyria), and hydrocephalus. Many children have feeding difficulties that are often multifactorial in nature. Endocrine issues affect a small number of individuals and most commonly include hypoglycemia (largely hypoinsulinemic hypoketotic hypoglycemia), hypothyroidism, and growth hormone deficiency.</Attribute>
                <XRef ID="NBK153722" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23946963</ID>
                <ID Source="BookShelf">NBK153722</ID>
              </Citation>
              <Citation Type="general">
                <ID Source="PubMed">27631024</ID>
              </Citation>
              <XRef ID="530313" DB="Orphanet" />
              <XRef ID="C4728213" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7816598" SubmissionDate="2023-12-12" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="NM_006218.4:c.1340_1366del|PIK3CA-related overgrowth syndrome" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004176907" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Clinical Genomics Laboratory, Washington University in St. Louis" OrgID="505219" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The PIK3CA c.1340_1366del (p.Pro447_Leu455del) variant was identified at an allelic fraction consistent with somatic origin. This variant has been reported in two individuals affected with PROS disorders (Kirstein AS et al., PMID: 31627436; Li D et al., PMID: 37264205). This variant has been reported in the ClinVar database as a pathogenic germline variant by one submitter (ClinVar ID: 2571196), and it has been reported in three cases in the cancer database COSMIC (Genomic Mutation ID: COSV56030552). The PIK3CA c.1340_1366del (p.Pro447_Leu455del) variant is absent from the general population (gnomAD v.3.1.2), indicating it is not a common variant. This variant is predicted to cause a change in the length of the protein due to an in-frame deletion of nine amino acids in a non-repeat region. This variant resides within a region, the C2 domain, amino acids 325-484, of PIK3CA that is defined as a critical functional domain (Zhao L et al., PMID: 18268322; Samuels Y et al., PMID: 15016963; Wu H et al., PMID: 19915146). In vitro functional studies show that this variant affects protein stability and hyperactivates the PI3K/AKT/TOR pathway and induces cell transformation (Croessmann S et al., PMID: 29284706). Based on an internally-developed protocol informed by the ACMG/AMP guidelines (Richards S et al., PMID: 25741868) and gene-specific practices from the ClinGen Criteria Specification Registry, the PIK3CA c.1340_1366del (p.Pro447_Leu455del) variant is classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006218.4:c.1340_1366del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PIK3CA-related overgrowth syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14038946</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7507665" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2023-07-16">
        <ClinVarSubmissionID localKey="131337|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004011510" DateUpdated="2024-07-15" DateCreated="2023-07-16" Type="SCV" Version="9" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="G" referenceAllele="GGCCAGTACCTCATGGATTAGAAGATTT" start="178928059" stop="178928086" variantLength="28" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7507665" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7816598" TraitType="Disease" MappingType="Name" MappingValue="PIK3CA-related overgrowth syndrome" MappingRef="Preferred">
        <MedGen CUI="C4728213" Name="PIK3CA related overgrowth syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

